15-Deoxy-Delta12,14-prostaglandin J2 inhibits HIV-1 transactivating protein, Tat, through covalent modification.
about
Combined bezafibrate and medroxyprogesterone acetate: potential novel therapy for acute myeloid leukaemiaPPAR-γ ligands repress TGFβ-induced myofibroblast differentiation by targeting the PI3K/Akt pathway: implications for therapy of fibrosis.Celastrol inhibits Tat-mediated human immunodeficiency virus (HIV) transcription and replication.Nuclear receptor signaling inhibits HIV-1 replication in macrophages through multiple trans-repression mechanismsTargeting of histone acetyltransferase p300 by cyclopentenone prostaglandin Δ(12)-PGJ(2) through covalent binding to Cys(1438)Interactions between prostaglandins, leukotrienes and HIV-1: possible implications for the central nervous system.Modification of cysteine residues by cyclopentenone prostaglandins: interplay with redox regulation of protein function.Strategies to Block HIV Transcription: Focus on Small Molecule Tat Inhibitors.Targeting HIV transcription: the quest for a functional cure.Didehydro-Cortistatin A: a new player in HIV-therapy?Improving combination antiretroviral therapy by targeting HIV-1 gene transcription.Leukotrienes inhibit early stages of HIV-1 infection in monocyte-derived microglia-like cellsProteomic identification of the candidate target proteins of 15-deoxy-delta12,14-prostaglandin J2.15-Deoxy-Δ12,14-Prostaglandin J2 Modifies Components of the Proteasome and Inhibits Inflammatory Responses in Human Endothelial Cells15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis.Structure-activity relationship analysis of curcumin analogues on anti-influenza virus activity.15-deoxy-Δ¹²,¹⁴ -prostaglandin J₂ inhibits human immunodeficiency virus-1 tat-induced monocyte chemoattractant protein-1/CCL2 production by blocking the extracellular signal-regulated kinase-1/2 signaling pathway independently of peroxisome proliferProstaglandin A1 inhibits the replication of bovine viral diarrhea virus.
P2860
Q28472176-3072A85A-0EF7-4443-86B8-B291E341057FQ33799182-A7062E94-14A5-4724-B9CC-B75B56E90265Q35119118-9937EAEF-8278-4AE7-97FF-83407E3338FBQ35274791-B297585C-ADEE-4EB5-90CA-57E8DFD653C3Q35851779-D8AA14A5-C786-4EA5-AE4B-FB03492703B7Q37974980-584ED80C-7FAA-4E86-882E-6CD3DBBB0F91Q38118666-8A374419-669E-4530-96B9-16C96F0D31A9Q38212101-4BD71E12-1E53-4BA1-AC78-F6228A93BB58Q38366762-F74FF432-83AE-4162-906A-020848A2FA48Q38440932-0C7E8A21-1E98-4DE8-BEC7-54AFF7E67331Q38856263-96473612-5C97-44C0-B726-AA070248DD35Q38906298-1A55D190-B854-4A6F-B94F-FE6100C6442BQ39162650-0AB1ECC6-DC73-42C9-9496-4D2F7EF33D9DQ39197422-B974B590-3795-4F99-987D-E375A08B5534Q40810593-E0B22013-4684-4D9B-A225-C67325F7A0CAQ42269819-F5D34390-497D-47A3-8DBB-AB016910FF7BQ45254835-B3E447CC-A9D8-4EB1-927D-87DE4D66BF29Q54255221-811BB881-5F58-4A3C-96AE-DC11AD9CE85D
P2860
15-Deoxy-Delta12,14-prostaglandin J2 inhibits HIV-1 transactivating protein, Tat, through covalent modification.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 March 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
15-Deoxy-Delta12,14-prostaglan ...... through covalent modification.
@en
15-Deoxy-Delta12,14-prostaglan ...... through covalent modification.
@nl
type
label
15-Deoxy-Delta12,14-prostaglan ...... through covalent modification.
@en
15-Deoxy-Delta12,14-prostaglan ...... through covalent modification.
@nl
prefLabel
15-Deoxy-Delta12,14-prostaglan ...... through covalent modification.
@en
15-Deoxy-Delta12,14-prostaglan ...... through covalent modification.
@nl
P2860
P50
P356
P1433
P1476
15-Deoxy-Delta12,14-prostaglan ...... through covalent modification
@en
P2093
Parisa Kalantari
P2860
P304
P356
10.1096/FJ.08-124982
P407
P577
2009-03-19T00:00:00Z